|
Clinical inquiries from DR-TB sites (N = 308)
|
|
Construction of treatment regimen
|
119 (38.6)
|
|
Management of adverse effect
|
74 (24.0)
|
|
Determination treatment duration
|
67 (21.8)
|
|
Validation of already prescribed regimen
|
30 (9.7)
|
|
Establishment of DR-TB diagnosis
|
17 (5.5)
|
|
Unknown
|
1 (0.3)
|
|
Recommendations of consilium (N = 471)
|
|
Construction of initial DR-TB regimen
|
102 (21.7)
|
|
Observation while on current regimen
|
78 (16.6)
|
|
Adherence counselling
|
66 (14.0)
|
|
Dose adjustment
|
36 (7.6)
|
|
Further diagnostic work up
|
35 (7.4)
|
|
Further clinical evaluation by specialist
|
32 (6.8)
|
|
Substitution of single agent in the regimen
|
30 (6.4)
|
|
Change of regimen (substituting 2 or more agents)
|
25 (5.3)
|
|
Adjunct medication
|
23 (4.9)
|
|
Withholding a single agent without substituting it
|
15 (3.2)
|
|
Withholding all DR-TB treatment for a while
|
13 (2.8)
|
|
Other recommendation
|
16 (3.4)
|
